Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Apr-24 4:30 PM View:  | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 24-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 25-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 24-Apr-24 | Planned Option Sale | 3,600 | $238.81 | $859,730.00 | (97%) 3.73K to 0.13K | |
| 25-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 23-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 25-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 23-Apr-24 | Planned Option Sale | 3,600 | $236.38 | $850,983.00 | (97%) 3.73K to 0.13K | |
| 23-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 22-Apr-24 | Planned Option Sale | 3,600 | $236.47 | $851,298.00 | (97%) 3.73K to 0.13K | |
| 23-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 22-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 23-Apr-24 4:30 PM View: | Dwek Raymond Director | United Therapeutics Corp. (UTHR) | 22-Apr-24 | Disposition | 3,000 | $234.06 | $702,180.00 | (63%) 4.75K to 1.75K | |
| 23-Apr-24 4:30 PM View: | Dwek Raymond Director | United Therapeutics Corp. (UTHR) | 22-Apr-24 | Option Exercise | 3,000 | $88.03 | $264,090.00 | 171% 1.75K to 4.75K | |
| 23-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 19-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 23-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 19-Apr-24 | Planned Option Sale | 3,600 | $236.91 | $852,876.00 | (97%) 3.73K to 0.13K | |
| 19-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 18-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 19-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 18-Apr-24 | Planned Option Sale | 3,600 | $237.91 | $856,462.00 | (97%) 3.73K to 0.13K | |
| 19-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 17-Apr-24 | Planned Option Sale | 3,600 | $235.70 | $848,528.00 | (97%) 3.73K to 0.13K | |
| 19-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 17-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 17-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 16-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 17-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 16-Apr-24 | Planned Option Sale | 3,600 | $232.05 | $835,392.00 | (97%) 3.73K to 0.13K | |
| 16-Apr-24 4:30 PM View: | Dwek Raymond Director | United Therapeutics Corp. (UTHR) | 15-Apr-24 | Disposition | 3,000 | $235.08 | $705,240.00 | (63%) 4.75K to 1.75K | |
| 17-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 15-Apr-24 | Planned Option Sale | 3,600 | $235.40 | $847,427.00 | (97%) 3.73K to 0.13K | |
| 16-Apr-24 4:30 PM View: | Dwek Raymond Director | United Therapeutics Corp. (UTHR) | 15-Apr-24 | Option Exercise | 3,000 | $88.03 | $264,090.00 | 171% 1.75K to 4.75K | |
| 17-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 15-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 15-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 12-Apr-24 | Planned Option Sale | 3,600 | $235.42 | $847,509.00 | (97%) 3.73K to 0.13K | |
| 15-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 12-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 15-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 11-Apr-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | 2769% 0.13K to 3.73K | |
| 15-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 11-Apr-24 | Planned Option Sale | 3,600 | $238.96 | $860,266.00 | (97%) 3.73K to 0.13K | |
| 11-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 10-Apr-24 | Planned Option Sale | 13,800 | $237.27 | $3,274,380.00 | (99%) 13.93K to 0.13K | |
| 11-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 10-Apr-24 | Option Exercise | 13,800 | $129.49 | $1,786,960.00 | 10615% 0.13K to 13.93K | |
| 11-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 09-Apr-24 | Planned Option Sale | 15,000 | $237.16 | $3,557,360.00 | (99%) 15.13K to 0.13K | |
| 11-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 09-Apr-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 09-Apr-24 4:30 PM View: | Dwek Raymond Director | United Therapeutics Corp. (UTHR) | 08-Apr-24 | Disposition | 4,000 | $236.96 | $947,840.00 | (70%) 5.75K to 1.75K | |
| 09-Apr-24 4:30 PM View: | Dwek Raymond Director | United Therapeutics Corp. (UTHR) | 08-Apr-24 | Option Exercise | 4,000 | $88.03 | $352,120.00 | 229% 1.75K to 5.75K | |
| 09-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 08-Apr-24 | Option Exercise | 5,060 | $129.49 | $655,219.00 | 3892% 0.13K to 5.19K | |
| 09-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 08-Apr-24 | Planned Option Sale | 5,060 | $237.52 | $1,201,850.00 | (97%) 5.19K to 0.13K | |
| 09-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 05-Apr-24 | Planned Option Sale | 15,000 | $235.06 | $3,525,890.00 | (99%) 15.13K to 0.13K | |
| 09-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 05-Apr-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 05-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 04-Apr-24 | Planned Option Sale | 15,000 | $233.27 | $3,499,070.00 | (99%) 15.13K to 0.13K | |
| 04-Apr-24 4:30 PM View: | Mahon Paul A EVP & General Counsel | United Therapeutics Corp. (UTHR) | 04-Apr-24 | Option Exercise | 6,000 | $117.76 | $706,560.00 | 16% 36.71K to 42.71K | |
| 05-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 04-Apr-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 04-Apr-24 4:30 PM View: | Mahon Paul A EVP & General Counsel | United Therapeutics Corp. (UTHR) | 04-Apr-24 | Planned Option Sale | 6,000 | $232.38 | $1,394,250.00 | (14%) 42.71K to 36.71K | |
| 05-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 03-Apr-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 05-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 03-Apr-24 | Planned Option Sale | 15,000 | $230.58 | $3,458,640.00 | (99%) 15.13K to 0.13K | |
| 03-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 02-Apr-24 | Planned Option Sale | 15,000 | $229.41 | $3,441,090.00 | (99%) 15.13K to 0.13K | |
| 03-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 02-Apr-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 03-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 01-Apr-24 | Planned Option Sale | 15,000 | $227.98 | $3,419,730.00 | (99%) 15.13K to 0.13K | |
| 03-Apr-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 01-Apr-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 29-Mar-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 28-Mar-24 | Option Exercise | 14,125 | $129.49 | $1,829,050.00 | 10865% 0.13K to 14.26K | |
| 29-Mar-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 28-Mar-24 | Planned Option Sale | 14,125 | $236.18 | $3,336,050.00 | (99%) 14.26K to 0.13K | |
| 29-Mar-24 4:30 PM View: | Mesa Nilda Director | United Therapeutics Corp. (UTHR) | 27-Mar-24 | Private Sale | 325 | $237.80 | $77,285.00 | (6%) 5.7K to 5.37K | |
| 29-Mar-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 27-Mar-24 | Planned Option Sale | 15,000 | $241.75 | $3,626,250.00 | (99%) 15.13K to 0.13K | |
| 29-Mar-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 27-Mar-24 | Option Exercise | 15,000 | $129.49 | $1,942,350.00 | 11539% 0.13K to 15.13K | |
| 27-Mar-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 26-Mar-24 | Planned Option Sale | 15,000 | $248.33 | $3,724,940.00 | (99%) 15.13K to 0.13K |
